virus blocking
Recently Published Documents


TOTAL DOCUMENTS

29
(FIVE YEARS 17)

H-INDEX

9
(FIVE YEARS 3)

2021 ◽  
Vol 15 (7) ◽  
pp. e0009637
Author(s):  
Heverton L. C. Dutra ◽  
Suzanne A. Ford ◽  
Scott L. Allen ◽  
Sarah R. Bordenstein ◽  
Stephen F. Chenoweth ◽  
...  

Wolbachia is currently at the forefront of global efforts to control arbovirus transmission from the vector Aedes aegypti. The use of Wolbachia relies on two phenotypes—cytoplasmic incompatibility (CI), conferred by cifA and cifB genes in prophage WO, and Wolbachia-mediated pathogen blocking (WMPB). These traits allow for local, self-sustaining reductions in transmission of dengue (DENV) following release of Wolbachia-infected A. aegypti. Here, aided by previous artificial selection experiment that generated Low and High pathogen blocking lines, we examined the potential link between WMPB and phage WO. We found no evidence that Wolbachia or phage WO relative densities predict DENV blocking strength across selected lines. However, selection resulted in reduced phage WO relative density for the Low WMPB line. The Low blocking line was previously shown to have reduced fitness as a result of selection. Through subsequent genomic analyses, we demonstrate that SNP variation underpinning selection for low blocking led to elevated frequency of potential deleterious SNPs on chromosome 1. The key region on chromosome 1 contains genes relating to cell cycle regulation, oxidative stress, transcriptional pausing, among others, that may have cascading effects on Wolbachia intracellular environment. We hypothesize that reduction in phage WO may be driven by changes in the loci directly under selection for blocking, or by the accumulation of predicted deleterious alleles in linkage disequilibrium with blocking loci resulting from hitchhiking. For the Low line with fewer phage WO, we also detected reduced expression of cifA and cifB CI genes, with patterns of expression varying between somatic and reproductive tissues. In conclusion, we propose that artificial selection for WMPB trait had corresponding impacts on phage WO densities, and also the transcription of CI-causing genes. Future studies may include a more detailed analysis of the regions the A. aegypti chromosome 1’s ability to affect WMPB and other Wolbachia-associated intrinsic factors such as phage WO.


2021 ◽  
Author(s):  
Vinicius M Mello ◽  
Cristiane M. Eller ◽  
Andreza L. Salvio ◽  
Felipe F. Nascimento ◽  
Camila M. Figueiredo ◽  
...  

In 2019, a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is trans-mitted via airborne route, caused a new pandemic namely, 'coronavirus disease 2019' (COVID-19). Although it is still debated whether the use of masks can prevent the transmission of SARS-CoV-2, no study has evaluated the virus-blocking efficacy of masks used by patients. We aimed to evaluate this efficacy of masks used by SARS-CoV-2-infected individuals. Data, masks used, and nasopharyngeal swab samples were obtained from these patients. Forty-five paired samples of nasopharyngeal swabs and masks were obtained and processed; the majority of masks were woven. Viral RNAs were amplified using quantitative reverse‐transcription polymerase chain reaction and detected only on the inner parts of masks. Median cycle threshold (CT) values of swabs and masks were 28.41 and 37.95, respectively. Statistically, there was a difference of ap-proximately 10 CT values between swabs and masks and no significant difference in CT values among different types of masks. There were statistically significant differences in CT values be-tween men and women and symptomatic and asymptomatic patients. Our findings suggest the blocking of the transmission of the virus by different types of masks and reinforce the use of masks by both infected and non-infected individuals.


Author(s):  
Max Sauter ◽  
Antje Blank ◽  
Felicitas Stoll ◽  
Natalie Lutz ◽  
Walter E. Haefeli ◽  
...  

AbstractBulevirtide is a first-in-class entry inhibitor of the hepatitis B and hepatitis delta virus blocking the sodium/bile acid co-transporter NTCP, and was recently approved for the treatment of hepatitis D as a priority medicine (prime) in an accelerated assessment by the European Medicines Agency. It is a very large lipopeptide comprising 47 amino acids in its sequence and a myristoylation at the N-terminus. For support of clinical development, we established highly sensitive plasma quantification assays using 100 μL of plasma, spanning concentrations of 0.1 to 100 ng/mL and 1 to 1000 ng/mL with the option to measure ten-fold diluted samples up to 10,000 ng/mL. Quantification was performed with UPLC-MS/MS measurements after extraction with protein precipitation. Both assays were fully validated according to the pertinent guidelines of the FDA and EMA, including incurred sample reanalyses and cross-validation using clinical study samples.


2021 ◽  
Vol 11 (1) ◽  
Author(s):  
João Silveira Moledo Gesto ◽  
Gabriel Sylvestre Ribeiro ◽  
Marcele Neves Rocha ◽  
Fernando Braga Stehling Dias ◽  
Julia Peixoto ◽  
...  

AbstractField release of Wolbachia-infected Aedes aegypti has emerged as a promising solution to manage the transmission of dengue, Zika and chikungunya in endemic areas across the globe. Through an efficient self-dispersing mechanism, and the ability to induce virus-blocking properties, Wolbachia offers an unmatched potential to gradually modify wild Ae. aegypti populations turning them unsuitable disease vectors. Here we describe a proof-of-concept field trial carried out in a small community of Niterói, greater Rio de Janeiro, Brazil. Following the release of Wolbachia-infected eggs, we report here a successful invasion and long-term establishment of the bacterium across the territory, as denoted by stable high-infection indexes (> 80%). We have also demonstrated that refractoriness to dengue and Zika viruses, either thorough oral-feeding or intra-thoracic saliva challenging assays, was maintained over the adaptation to the natural environment of Southeastern Brazil. These findings further support Wolbachia’s ability to invade local Ae. aegypti populations and impair disease transmission, and will pave the way for future epidemiological and economic impact assessments.


2021 ◽  
Author(s):  
Satashree Paul

Researchers revealed that the nanobodies can bind tightly to the spike protein of the SARS-CoV-2 virus, blocking the pathway of human cells and preventing infections.


2021 ◽  
Author(s):  
Minki Kang ◽  
Na-Yoon Jang ◽  
Young-Jun Kim ◽  
Hyo-Jin Ro ◽  
Dabin Kim ◽  
...  

Author(s):  
João Silveira Moledo Gesto ◽  
Gabriel Sylvestre Ribeiro ◽  
Marcele Neves Rocha ◽  
Fernando Braga Stehling Dias ◽  
Julia Peixoto ◽  
...  

AbstractField release of Wolbachia-infected Aedes aegypti has emerged as a promising solution to manage the transmission of dengue, Zika and chikungunya in endemic areas across the globe. Through an efficient self-dispersing mechanism, and the ability to induce virus-blocking properties, Wolbachia offers an unmatched potential to gradually modify wild Ae. aegypti populations turning them unsuitable disease vectors. Here in this work, a proof-of-concept field trial was carried out in a small community of Niterói, greater Rio de Janeiro. Following the release of Wolbachia-infected eggs, we reported a successful invasion and long-term establishment of the bacterium across the territory, as denoted by stable high-infection indexes (>80%). We have also demonstrated that refractoriness to dengue and Zika viruses, either thorough oral-feeding or intra-thoracic saliva challenging assays, were maintained over the adaptation to the natural environment of Southeastern Brazil. These findings further support Wolbachia’s ability to invade local Ae. aegypti populations and impair disease transmission, and shall pave the way for future epidemiological and economic impact assessments.


2020 ◽  
Vol 3 (1) ◽  
Author(s):  
Cassandra Koh ◽  
M. Nurul Islam ◽  
Yixin H. Ye ◽  
Nunya Chotiwan ◽  
Barbara Graham ◽  
...  

AbstractCompetition between viruses and Wolbachia for host lipids is a proposed mechanism of Wolbachia-mediated virus blocking in insects. Yet, the metabolomic interaction between virus and symbiont within the mosquito has not been clearly defined. We compare the lipid profiles of Aedes aegypti mosquitoes bearing mono- or dual-infections of the Wolbachia wMel strain and dengue virus serotype 3 (DENV3). We found metabolic signatures of infection-induced intracellular events but little evidence to support direct competition between Wolbachia and virus for host lipids. Lipid profiles of dual-infected mosquitoes resemble those of DENV3 mono-infected mosquitoes, suggesting virus-driven modulation dominates over that of Wolbachia. Interestingly, knockdown of key metabolic enzymes suggests cardiolipins are host factors for DENV3 and Wolbachia replication. These findings define the Wolbachia-DENV3 metabolic interaction as indirectly antagonistic, rather than directly competitive, and reveal new research avenues with respect to mosquito × virus interactions at the molecular level.


2020 ◽  
Vol 117 (39) ◽  
pp. 24475-24483 ◽  
Author(s):  
Gayathri Manokaran ◽  
Heather A. Flores ◽  
Conor T. Dickson ◽  
Vinod K. Narayana ◽  
Komal Kanojia ◽  
...  

Wolbachia-infected mosquitoes are refractory to flavivirus infections, but the role of lipids in Wolbachia-mediated virus blocking remains to be elucidated. Here, we use liquid chromatography mass spectrometry to provide a comprehensive picture of the lipidome of Aedes aegypti (Aag2) cells infected with Wolbachia only, either dengue or Zika virus only, and Wolbachia-infected Aag2 cells superinfected with either dengue or Zika virus. This approach identifies a class of lipids, acyl-carnitines, as being down-regulated during Wolbachia infection. Furthermore, treatment with an acyl-carnitine inhibitor assigns a crucial role for acyl-carnitines in the replication of dengue and Zika viruses. In contrast, depletion of acyl-carnitines increases Wolbachia density while addition of commercially available acyl-carnitines impairs Wolbachia production. Finally, we show an increase in flavivirus infection of Wolbachia-infected cells with the addition of acyl-carnitines. This study uncovers a previously unknown role for acyl-carnitines in this tripartite interaction that suggests an important and broad mechanism that underpins Wolbachia-mediated pathogen blocking.


2020 ◽  
Author(s):  
Wei-Hao Dou ◽  
Jin-Hua Xiao ◽  
Da-Wei Huang

Abstract Background: Wolbachia is a type of intracellular symbiotic bacteria widely distributed in arthropods including most insects and nematodes. These maternally inherited bacteria can regulate the host's reproductive system in various ways for their own vertical transmission. Since the identification of Wolbachia in many insects, the relationship between Wolbachia and host has attracted great interest. Wolbachia must rely on the host cells to survive, and they can also improve the fitness of the host through a variety of ways. However, the molecular basis of interaction between Wolbachia and their host has not been well resolved so far. Results: We performed transcriptome sequencing on testis tissues of adults of Wolbachia-infected and Wolbachia-free Drosophila melanogaster. Comparison of gene expression profiles revealed 471 significantly differentially expressed genes that involved in cell metabolism, cell membrane component correlation and hydrolysis process.Conclusions: Our results show that lipid and carbohydrate metabolism are more active in Wolbachia-infected testis than in Wolbachia free testis. This work strengthens our general understanding of the Wolbachia-host intracellular relationship and may provide a new perspective for Wolbachia-mediated virus-blocking.


Sign in / Sign up

Export Citation Format

Share Document